Whether you work in big pharma, a biosimilars development company, a clinical service organisation, a regulatory body or in commercial investment and finance, the Biosimilar Index provides a clear window on the world of biosimilar drugs and their developers. You can purchase this FirstWord report, here. (Source: FirstWord, March 2014).
Connected. Community.
